Sign up for Table of Contents Alerts.
Email this page
Print this page
Research Paper
Regulation of Multidrug Resistance by Ribosomal Protein L6 in Gastric Cancer Cells
Jingping Du, Yongquan Shi, Yanglin Pan, Xiaohang Jin, Changjiang Liu, Na Liu, Quanli Han, Yuanyuan Lu, Taidong Qiao, Daiming Fan
volume 4 | issue 2
February 2005Pages: 242-247
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Ribosomal proteins (RP) L6 was previously identified as an up-regulated gene in multidrug-resistant gastric cancer cells SGC7901/ADR comparing to its parental cells SGC7901 by subtractive hybridization. The aim of this study was to explore the roles of RPL6 in multidrug resistance (MDR) in gastric cancer cells. Northern and Western blot analysis confirmed that RPL6 was overexpressed in SGC7901/ADR cells. By gene transfection, RPL6 was genetically up-regulated in SGC7901 or down-regulated in SGC7901/ADR cells. Up-regulation of RPL6 was associated with enhanced resistance to multiple anticancer drugs (adriamycin, vincristine, etoposide, 5-fludrouracil and cisplatin) and to adriamycin-induced apoptosis. Down-regulation of RPL6 reversed MDR and sensitized cells to adriamycin-induced apoptosis. Alteration of RPL6 showed no obvious influence on intracellular adriamycin accumulation, glutathione content and expression of glutathione S-transferase. RPL6 could up-regulate Bcl-2 and down-regulate Bax in cells. Together, this work demonstrates that RPL6 could regulate MDR in gastric cancer cells by suppressing drug-induced apoptosis.
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.




